Barclays »

Diamedica Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Diamedica Therapeutics (DMAC) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Diamedica Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Diamedica Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Diamedica Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2025-09-30 $312k 45k 6.87
2025-06-30 $191k 49k 3.92
2025-03-31 $69k 18k 3.78
2024-12-31 $151k 28k 5.45
2021-09-30 $19k 4.6k 4.12
2021-06-30 $6.0k 1.4k 4.26
2021-03-31 $31k 3.4k 9.09